Dr. Thomas Seth Kupper, MD

Dr. Kupper practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.

Dr. Kupper's NPI, 1548227945, was assigned on April 28, 2006. Dr. Kupper graduated from Yale University School of Medicine in 1981. Dr. Kupper holds Massachusetts license 76281.

Dr. Kupper's primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.

Dr. Kupper's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dr. Kupper is also affiliated with Brigham and Women's Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Kupper to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kupper practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Kupper's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kupper is licensed in Massachusetts.

CMS data shows 71 Medicare services from Dr. Kupper across 2 procedure codes in 2024, all of them office visits, for 56 Medicare patients. Medicare paid $5,772 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 56 Medicare patients who saw Dr. Kupper in 2024. The largest group is 75 to 84, with 31 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kupper's median patient age at 72, with 41% women.

In 2023, Dr. Kupper wrote 16 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $150,771 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

Dr. Kupper accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kupper as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 97 papers to Dr. Kupper, published from 2010 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Lymphoma, T-Cell, Cutaneous, Skin Neoplasms and Skin. Dr. Kupper has published most often in J Invest Dermatol. Dr. Kupper's most frequent co-authors are Rachael A. Clark, MD, PhD, David Christopher Fisher, MD and John Thomas O'Malley, MD, PhD.

CMS Open Payments shows 8 general payments to Dr. Kupper from 2 drug and device companies from 2017 to 2019. Consulting fees make up the largest share, 98% of the total. Sanofi and Genzyme US Companies paid the most, $7,022.

Dr. Kupper graduated from Yale University School of Medicine in 1981.